RICCI, ANGELA DALIA

RICCI, ANGELA DALIA  

Risultati 1 - 20 di 52 (tempo di esecuzione: 0.029 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Anti-EGFR monoclonal antibodies in advanced biliary tract cancer: A systematic review and meta-analysis Rizzo A.; Frega G.; Ricci A.D.; Palloni A.; Abbati F.; de Lorenzo S.; Deserti M.; Tavolari S.; Brandi G. 2020-01-01 IN VIVO - 1.01 Articolo in rivista -
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study Ricci A.D.; Pusceddu S.; Panzuto F.; Gelsomino F.; Massironi S.; De Angelis C.G.; Modica R.; Ricco G.; Torchio M.; Rinzivillo M.; Prinzi N.; Rizzi F.; Lamberti G.; Campana D. 2022-01-01 JOURNAL OF CLINICAL MEDICINE - 1.01 Articolo in rivista jcm-11-00713-v2.pdf
Bayesian Analysis Supports Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma Rizzo A.; Ricci A.D.; Brandi G. 2021-01-01 LIVER CANCER - 1.01 Articolo in rivista -
Circulating tumor DNA in biliary tract cancer: Current evidence and future perspectives Rizzo A.; Ricci A.D.; Tavolari S.; Brandi G. 2020-01-01 CANCER GENOMICS & PROTEOMICS. - 1.01 Articolo in rivista -
Combination therapy of dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer Rizzo A.; Ricci A.D.; Brandi G. 2021-01-01 HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL - 1.04 Replica / breve intervento (e simili) -
Combining immune checkpoint inhibitors with locoregional therapies in hepatocellular carcinoma Rizzo A.; Ricci A.D.; Brandi G. 2022-01-01 EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT - 1.01 Articolo in rivista -
Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: A meta-analysis Rizzo A.; Mollica V.; Santoni M.; Rosellini M.; Marchetti A.; Ricci A.D.; Grilli G.; Greco A.; Montironi R.; Ardizzoni A.; Massari F. 2021-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
Detecting and targeting NTRK gene fusions in cholangiocarcinoma: news and perspectives Rizzo A.; Ricci A.D.; Brandi G. 2021-01-01 EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT - 1.01 Articolo in rivista -
The DNA damage repair (DDR) pathway in biliary tract cancer (BTC): A new Pandora's box? Ricci A.D.; Rizzo A.; Brandi G. 2020-01-01 ESMO OPEN - 1.01 Articolo in rivista -
Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysis Alessandro Rizzo; Margherita Nannini; Marco Novelli; Angela Dalia Ricci; Valerio Di Scioscio; Maria Abbondanza Pantaleo 2020-01-01 THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - 1.01 Articolo in rivista 1758835920936932.pdf
Dual immune checkpoint blockade in hepatocellular carcinoma: where do we stand? Riccardo Carloni, Alessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, Alessandro Di Federico, Andrea Palloni, Mariacristina Di Marco, Gennaro Gadaleta-Caldarola, Giovanni Brandi 2022-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
Durvalumab: an investigational anti-PD-L1 antibody for the treatment of biliary tract cancer Rizzo A.; Ricci A.D.; Brandi G. 2021-01-01 EXPERT OPINION ON INVESTIGATIONAL DRUGS - 1.01 Articolo in rivista -
The (Eternal) Debate on Microwave Ablation Versus Radiofrequency Ablation in BCLC-A Hepatocellular Carcinoma Ricci A.D.; Rizzo A.; Bonucci C.; Tavolari S.; Palloni A.; Frega G.; Mollica V.; Tober N.; Mazzotta E.; Felicani C.; Serra C.; Brandi G. 2020-01-01 IN VIVO - 1.01 Articolo in rivista -
Experimental HER2- targeted therapies for biliary tract cancer Rizzo A.; Ricci A.D.; Bonucci C.; Tober N.; Palloni A.; Frega G.; Brandi G. 2021-01-01 EXPERT OPINION ON INVESTIGATIONAL DRUGS - 1.01 Articolo in rivista -
Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trials Rizzo A.; Mollica V.; Rosellini M.; Marchetti A.; Ricci A.D.; Fiorentino M.; Battelli N.; Santoni M.; Massari F. 2021-01-01 PATHOLOGY RESEARCH AND PRACTICE - 1.01 Articolo in rivista -
FGFR inhibitors in elderly patients with advanced biliary tract cancer: an unsolved issue Rizzo A.; Ricci A.D.; Frega G.; Di Federico A.; Brandi G. 2021-01-01 EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY - 1.01 Articolo in rivista -
First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges Rizzo A.; Ricci A.D.; Gadaleta-Caldarola G.; Brandi G. 2021-01-01 EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY - 1.01 Articolo in rivista -
The functioning side of the pancreas: a review on insulinomas Maggio I.; Mollica V.; Brighi N.; Lamberti G.; Manuzzi L.; Ricci A.D.; Campana D. 2020-01-01 JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION - 1.01 Articolo in rivista -
Futibatinib, an investigational agent for the treatment of intrahepatic cholangiocarcinoma: evidence to date and future perspectives Rizzo A.; Ricci A.D.; Brandi G. 2021-01-01 EXPERT OPINION ON INVESTIGATIONAL DRUGS - 1.01 Articolo in rivista -
Hacking pancreatic cancer: Present and future of personalized medicine Di Federico A.; Tateo V.; Parisi C.; Formica F.; Carloni R.; Frega G.; Rizzo A.; Ricci D.; Di Marco M.; Palloni A.; Brandi G. 2021-01-01 PHARMACEUTICALS - 1.01 Articolo in rivista -